32400011000001107: Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)
\UK product\Virtual medicinal product\Co-amoxiclav 875mg/125mg tablets\Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)
\UK product\Virtual therapeutic moiety\Co-amoxiclav\Co-amoxiclav 875mg/125mg tablets\Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)

\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Product containing penicillin (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 875mg/125mg tablets\Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing beta-lactam\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 875mg/125mg tablets\Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiinfective agent (product)\Medicinal product acting as antibacterial agent (product)\Medicinal product containing beta-lactam and acting as antibacterial agent (product)\Medicinal product containing penicillin and acting as antibacterial agent (product)\Co-amoxiclav\Co-amoxiclav 875mg/125mg tablets\Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

98589101000001113 Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

98589201000001118 Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Is a	Co-amoxiclav 875mg/125mg tablets	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Is a	Co-amoxiclav 875mg/125mg tablets	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Is a	Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has active ingredient	Amoxicillin	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has active ingredient	Clavulanate potassium	false	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has manufactured dose form	Conventional release oral tablet	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has specific active ingredient	Clavulanate potassium	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has specific active ingredient	Amoxicillin trihydrate	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Amoxicillin	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has NHS dm+d (dictionary of medicines and devices) basis of strength substance	Clavulanic acid	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has basis of strength substance	Amoxicillin	true	Inferred relationship	Existential restriction modifier
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Has basis of strength substance	Clavulanic acid	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd) 14 tablet 2 x 7 tablets	Has AMP	True	Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
98589101000001113	Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
98589201000001118	Co-amoxiclav 875mg/125mg tablets (Brown & Burk UK Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module